Diabetic Gastroparesis Study 05
- First Posted Date
- 2018-12-26
- Last Posted Date
- 2021-12-15
- Lead Sponsor
- Allergan
- Target Recruit Count
- 202
- Registration Number
- NCT03786380
- Locations
- 🇺🇸
Rocky Mountain Diabetes and Osteoporosis Center, PA, Idaho Falls, Idaho, United States
🇺🇸University of Pennsylvania, Philadelphia, Pennsylvania, United States
🇺🇸Preferred Primary Care Physicians, Inc., Pittsburgh, Pennsylvania, United States
12-Week Placebo-controlled Study of Atogepant for the Preventive Treatment of Migraine in Participants With Episodic Migraine
- First Posted Date
- 2018-12-17
- Last Posted Date
- 2021-07-09
- Lead Sponsor
- Allergan
- Target Recruit Count
- 910
- Registration Number
- NCT03777059
- Locations
- 🇺🇸
Advanced Research Associates, Glendale, Arizona, United States
🇺🇸Orange Grove Family Practice, Tucson, Arizona, United States
🇺🇸Principals Research Group, Hot Springs, Arkansas, United States
Dynamic Optical Coherence Tomography(D-OCT) Aging Study: A Preliminary Evaluation of Structural Differences Between Young and Aged Skin, Cellulite and Atrophic Acne Scars in Female Caucasian Subjects With Fitzpatrick Skin Types I-III Utilizing Non-invasive in Vivo D-OCT.
- Conditions
- Skin Care
- Interventions
- Device: Skin ImagingOther: Facial Cleanser
- First Posted Date
- 2018-12-06
- Last Posted Date
- 2019-10-31
- Lead Sponsor
- Allergan
- Target Recruit Count
- 99
- Registration Number
- NCT03767400
- Locations
- 🇺🇸
Skinmedica Clinical Research and Innovation Center, Irvine, California, United States
JUVÉDERM® VOLITE™ XC for Cheek Skin Smoothness
- Conditions
- Skin Smoothness of the Cheeks
- Interventions
- Device: JUVÉDERM VOLITE™ XC
- First Posted Date
- 2018-11-02
- Last Posted Date
- 2022-12-19
- Lead Sponsor
- Allergan
- Target Recruit Count
- 209
- Registration Number
- NCT03728309
- Locations
- 🇺🇸
Ava MD, Santa Monica, California, United States
🇺🇸Facial Plastic Surgery Center /ID# 234876, Baltimore, Maryland, United States
🇺🇸Dallas Center for Dermatology and Aesthetics /ID# 234452, Dallas, Texas, United States
A Study to Evaluate Participant Satisfaction With Facial Appearance Overall and the Aesthetic and Psychosocial Impact of Combined Facial Treatment
- Conditions
- Facial Rhytides, Skin Folds, Loss of Volume and Skin Quality
- Interventions
- First Posted Date
- 2018-10-19
- Last Posted Date
- 2023-10-31
- Lead Sponsor
- Allergan
- Target Recruit Count
- 59
- Registration Number
- NCT03712449
- Locations
- 🇨🇦
Project Skin MD Vancouver, Vancouver, British Columbia, Canada
🇨🇦Pacific Derm, Vancouver, British Columbia, Canada
🇨🇦Carruthers & Humphrey Cosmetic Dermatology, Vancouver, British Columbia, Canada
Study of the Safety and Effectiveness of JUVÉDERM VOLUX™ XC Injectable Gel for Restoring Jawline Definition
- Conditions
- Jawline Definition
- Interventions
- Device: VOLUX XCOther: No-treatment control
- First Posted Date
- 2018-10-19
- Last Posted Date
- 2023-01-04
- Lead Sponsor
- Allergan
- Target Recruit Count
- 206
- Registration Number
- NCT03712137
- Locations
- 🇺🇸
Center aesthetic and dermatology, New York, New York, United States
🇺🇸Total Skin and Beauty Dermatology Center, PC, Birmingham, Alabama, United States
🇺🇸DeNova Research dba Arano, LLC, Chicago, Illinois, United States
Study to Evaluate the Safety and Tolerability of Treatment With Atogepant 60 mg Daily for the Prevention of Migraine in Participants With Episodic Migraine
- Conditions
- Episodic Migraine
- Interventions
- Drug: Standard of Care (SOC) Migraine Preventive Medication
- First Posted Date
- 2018-10-09
- Last Posted Date
- 2021-06-15
- Lead Sponsor
- Allergan
- Target Recruit Count
- 744
- Registration Number
- NCT03700320
- Locations
- 🇺🇸
iResearch Atlanta, Decatur, Georgia, United States
🇺🇸FutureSearch Trials of Dallas, LP, Dallas, Texas, United States
🇺🇸Rapid Medical Research, Inc., Cleveland, Ohio, United States
Evaluation of the Safety and Effectiveness of BELKYRA® Inj. for the Treatment of Patients With Submental Fullness Due to Submental Fat: A Postmarketing Surveillance Study in Korea
- First Posted Date
- 2018-10-01
- Last Posted Date
- 2020-12-07
- Lead Sponsor
- Allergan
- Target Recruit Count
- 71
- Registration Number
- NCT03691415
- Locations
- 🇰🇷
Oracle-Dermatology, Daejeon, Korea, Republic of
🇰🇷(Apgujeong) Oracle-Dermatology, Seoul, Korea, Republic of
🇰🇷Dream-Dermatology, Seoul, Korea, Republic of
Long-term 24-month Follow-up Study on Safety and Maintenance of Efficacy of ATX-101 (Sodium Deoxycholate Injection)
- First Posted Date
- 2018-09-24
- Last Posted Date
- 2018-09-24
- Lead Sponsor
- Allergan
- Target Recruit Count
- 201
- Registration Number
- NCT03682471
- Locations
- 🇩🇪
Licca Clinical Research Institute, Augsburg, Germany
🇩🇪Dr. Beatrice Gerlach, Dresden, Germany
🇩🇪Hautarztpraxis Cutanis, Freiburg, Germany
XEN-45 Gel Stent Versus Trabeculectomy in Glaucoma: Gold-Standard Pathway Study (GPS)
- Conditions
- Glaucoma
- Interventions
- Procedure: TrabeculectomyDevice: XEN-45 Gel Stent
- First Posted Date
- 2018-08-31
- Last Posted Date
- 2022-07-21
- Lead Sponsor
- Allergan
- Target Recruit Count
- 158
- Registration Number
- NCT03654885
- Locations
- 🇺🇸
Wills Eye Institute /ID# 233645, Philadelphia, Pennsylvania, United States
🇺🇸Houston Eye Associates /ID# 233621, Houston, Texas, United States
🇺🇸Nashville Vision Associates /ID# 233644, Nashville, Tennessee, United States